Edwards Lifesciences (EW) Other Non-Current Assets (2009 - 2026)

Edwards Lifesciences' Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $738.9 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 0.51% year-over-year to $738.9 million; the TTM figure through Mar 2026 stood at $738.9 million (down 0.51% YoY), while the FY2025 annual figure was $730.2 million, up 2624.63% from the prior year.
• Other Non-Current Assets was $738.9 million for Q1 2026 at Edwards Lifesciences, up from $730.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $767.6 million in Q1 2024 to a low of $26.8 million in Q4 2024.
• Historically, Other Non-Current Assets has averaged $424.6 million across 5 years, with a median of $316.5 million in 2022.
• Biggest YoY gain for Other Non-Current Assets was 2624.63% in 2025; the steepest drop was 94.94% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $299.1 million in 2022, then gained by 4.01% to $311.1 million in 2023, then plunged by 91.39% to $26.8 million in 2024, then soared by 2624.63% to $730.2 million in 2025, then rose by 1.19% to $738.9 million in 2026.
• The last three Other Non-Current Assets figures came in at $738.9 million (Q1 2026), $730.2 million (Q4 2025), and $34.6 million (Q3 2025), per Business Quant data.